Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
- Poster presentation
- Open Access
Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients
Journal for ImmunoTherapy of Cancer volume 2, Article number: P198 (2014)
The immune microenvironment is important to the pathophysiology of head and neck squamous cell carcinoma (HNSCC). Our aim was to investigate the prognostic significance of tumour-infiltrating lymphocytes (TILs) in operable tongue cancer patients treated with curative surgery and adjuvant radiotherapy with or without chemotherapy.
Patients and methods
The presence of CD3+, CD4+, CD8+ and FOXP3+ TILs in tumor tissues obtained from 93 patients during surgery were examined by immunohistochemistry. Correlation between clinicopathological features and TILs was investigated. The prognostic roles of TILs for local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS), distant metastasis-free survival (DMFS) and overall survival (OS) were analyzed.
Median follow up time was 31.4 months (range, 0.2-99.8 months). Higher number of CD4+ cells (p = 0.006), higher CD4/FOXP3 ratio (p = 0.012), lower CD3/CD4 ratio (p = 0.043), and higher CD4/CD8 ratio (p = 0.006) were correlated with the absence of lymphovascularinvasion (LVI). Patients with lower FOXP3+ TILs and higher CD8/FOXP3 ratio had marginally better RRFS (p = 0.071, and p = 0.069, respectively) (Figure 1 and Figure 2.). Patients with higher CD4/CD3 ratio had a significantly better DMFS (p = 0.036) (Figure 3).
CD4+ TILs and its ratio to other TILs were inversely correlated with LVI. Higher CD4/CD3 ratio predicts better DMFS. Prognostic role of FOXP3 in RRFS was marginally significant and warrants further investigation.
About this article
Cite this article
Chen, W., Chang, Y., Kuo, S. et al. Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients. j. immunotherapy cancer 2, P198 (2014). https://doi.org/10.1186/2051-1426-2-S3-P198
- Overall Survival
- Squamous Cell Carcinoma
- Clinicopathological Feature
- Prognostic Significance
- Adjuvant Radiotherapy